BW-50218

N/A

Report date: 2026/05/15 20:01:45
NME

Base Information

Drug NameBW-50218
Drug Alias NameBW-50218BW50218
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTransthyretin modulators
TargetsTransthyretin
Therapy Area/IndicationsCardiomyopathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Argo Biopharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Argo Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCardiomyopathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A